Therapy that removes harmful immune B-cells in MS may also mobilize protective, gut-derived B-cells into the nervous system, a study shows.

B-cell depletion therapies, in which B cells of the immune system that may drive disease activity in multiple sclerosis (MS) ...

B-cell depletion has become an important area of research in autoimmune disease as developers investigate whether deeper and more sustained depletion may support longer periods of ...

Memory B cells and tertiary lymphoid structures predicted BCG response and longer recurrence free survival in non muscle ...

B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...

B-cell depletion therapies in multiple sclerosis (MS) work in part by mobilizing protective B cells from the gut.

B cells are white blood cells that form a core part of the body's adaptive immune system, enabling it to recognize specific infections, remember them, and mount a targeted response by producing ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...